| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 2592 |
| 1 | LANSOPRAZOLE | 1982 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 1884 |
| 3 | ESOMEPRAZOLE SODIUM | 1696 |
| 4 | PANTOPRAZOLE SODIUM | 1071 |
| 5 | DEXLANSOPRAZOLE | 741 |
| 6 | OMEPRAZOLE | 316 |
| 7 | EXENATIDE | 128 |
| 8 | PANTOPRAZOLE | 126 |
| 9 | METFORMIN | 107 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INHALANT | 1 | 0.0222 |
| 1 | DEXLANSOPRAZOLE | 741 | 0.0212 |
| 2 | LANSOPRAZOLE | 1982 | 0.0140 |
| 3 | PANTOPRAZOLE SODIUM | 1071 | 0.0104 |
| 4 | ESOMEPRAZOLE SODIUM | 1696 | 0.0103 |
| 5 | NERATINIB | 18 | 0.0103 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 1884 | 0.0095 |
| 7 | OMEPRAZOLE AND SODIUM BICARBONATE | 21 | 0.0077 |
| 8 | OMEPRAZOLE MAGNESIUM | 2592 | 0.0074 |
| 9 | ANORECTAL OINTMENT | 1 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 2161 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 298 |
| 2 | GLP-1 Receptor Agonist [EPC] | 238 |
| 3 | Corticosteroid [EPC] | 154 |
| 4 | Benzodiazepine [EPC] | 152 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 141 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 108 |
| 7 | Insulin Analog [EPC] | 103 |
| 8 | Provitamin D2 Compound [EPC] | 94 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 86 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 2161 | 0.0050 |
| 1 | RNA Synthetase Inhibitor Antibacterial [EPC] | 15 | 0.0019 |
| 2 | Bismuth [EPC] | 7 | 0.0017 |
| 3 | Methylating Agent [EPC] | 1 | 0.0013 |
| 4 | GLP-1 Receptor Agonist [EPC] | 238 | 0.0013 |
| 5 | Aluminum Complex [EPC] | 17 | 0.0010 |
| 6 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0009 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0008 |
| 8 | Pyridone [EPC] | 23 | 0.0008 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 10 | 0.0007 |